000953.SHE Guangxi Hechi Chemical Co Ltd
- Market cap
- CNY 1.72B
- P/E
- -
- P/B
- 11.11x
- ROE
- 1.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 000953.SHE undervalued?
Graham numberThe Graham number of Guangxi Hechi Chemical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Guangxi Hechi Chemical Co Ltd fundamental analysis
No fundamental analysis for Guangxi Hechi Chemical Co Ltd yet.
Guangxi Hechi Chemical Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Guangxi Hechi Chemical Co Ltd
Guangxi Chisage Fine Chemical Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, urea, and fine chemicals in China and internationally. The company offers hydroxychloroquine side chains, chloroquine side chains, and dioxane. It also provides antimalarial drugs, progestins, nutritional supplements, and synthetic ammonia. The company sells its products under the Qunshan brand. In add…
Full company profileGuangxi Hechi Chemical Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Guangxi Hechi Chemical Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 398M | 221M | 231M | 139M | 244M | 162M | 161M | 187M | 212M | 180M | 129M |
| Gross Profit | -71.8M | -16.4M | -46.7M | 3.05M | 91.4M | 37.5M | 11.3M | 20.6M | 30.0M | 31.0M | 20.3M |
| Operating Income | -137M | -40.1M | -272M | -62.8M | 41.0M | 12.9M | -101M | -12.3M | 94.5M | 9.69M | 3.80M |
| EBITDA | -48.9M | 106M | -201M | -5.07M | 57.8M | 30.5M | -82.7M | 7.56M | 110M | 25.6M | 2.95M |
| Net Income | -142M | 29.5M | -274M | -60.9M | 30.9M | 10.0M | -100M | -11.6M | 79.3M | 6.53M | 1.51M |
| EPS | -0.48 | 0.10 | -0.93 | -0.21 | 0.09 | 0.03 | -0.27 | -0.03 | 0.22 | 0.02 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 785M | 818M | 387M | 345M | 376M | 396M | 287M | 281M | 333M | 266M | 273M |
| Total Liabilities | 874M | 795M | 637M | 309M | 194M | 202M | 192M | 198M | 171M | 95.2M | 99.3M |
| Shareholders' Equity | -89.1M | 23.3M | -250M | 23.4M | 167M | 177M | 77.8M | 66.6M | 145M | 153M | 155M |
| Cash & Short-term Investments | 145M | 234M | 5.08M | 42.1M | 84.2M | 85.3M | 56.2M | 64.6M | 89.2M | 55.9M | 45.4M |
| Total Debt | 189M | 742M | 5.00M | 5.00M | 5.01M | 137M | 5.00M | 144M | 123M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 107M | -333M | -52.5M | -11.1M | 67.1M | 6.71M | 800K | 20.9M | -28.0M | 51.9M | - |
| Capital Expenditure | 26.6M | 11.7M | 872K | 18.6M | 18.6M | 5.54M | 33.0M | 12.4M | 16.4M | 7.52M | 2.93M |
| Free Cash Flow | 80.5M | -345M | -53.3M | -11.1M | 48.5M | 1.17M | -32.2M | 8.57M | -44.4M | 44.4M | -26.6M |
| Ratios | |||||||||||
| ROE | - | 126.4% | - | -260.0% | 18.5% | 5.6% | -129.0% | -17.4% | 54.6% | 4.3% | 1.0% |
| ROA | -18.1% | 3.6% | -70.7% | -17.7% | 8.2% | 2.5% | -35.0% | -4.1% | 23.8% | 2.5% | 0.6% |
| Net Profit Margin | -35.6% | 13.3% | -118.5% | -43.9% | 12.7% | 6.2% | -62.5% | -6.2% | 37.5% | 3.6% | 1.2% |
| Debt to Equity | - | 31.85x | - | 0.21x | 0.03x | 0.77x | 0.06x | 2.16x | 0.85x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Guangxi Hechi Chemical Co Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- May 27, 2003
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | CNY 165K | 0.00 | 0.2% |
| 2023 | CNY 171K | 0.00 | - |
| 2022 | CNY 142K | 0.00 | - |
| 2021 | CNY 574K | 0.00 | 5.7% |
| 2020 | CNY 602K | 0.00 | 1.9% |
| 2019 | CNY 382K | 0.00 | - |
| 2018 | CNY 382K | 0.00 | - |
| 2017 | CNY 10.3M | 0.04 | 34.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 13:10 on Nov 13, 2006.
Who owns Guangxi Hechi Chemical Co Ltd
- Insiders 40.14%
- Institutions 0.80%
- Public & others 59.06%
- Shares outstanding 366M
- Free float 237M
Guangxi Hechi Chemical Co Ltd company profile
- Company name
- Guangxi Hechi Chemical Co Ltd
- Ticker
- 000953.SHE
- ISIN
- CNE000001105
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Sep 3, 1999
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 170
- Fiscal year end
- December
- Address
- No. 40, Liujia Town, Hechi, China, 547007
- Phone
- 86 77 8226 6882
- Website
- chisage.com
About Guangxi Hechi Chemical Co Ltd
Guangxi Chisage Fine Chemical Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, urea, and fine chemicals in China and internationally. The company offers hydroxychloroquine side chains, chloroquine side chains, and dioxane. It also provides antimalarial drugs, progestins, nutritional supplements, and synthetic ammonia. The company sells its products under the Qunshan brand. In addition, it engages in the wholesale and retail of fertilizers, feed, and chemical products; consulting and technical services; import of new chemical substances; import and export of pharmaceuticals, goods, and technology; domestic trade and sales agency; and trade brokerage activities. The company was formerly known as Guangxi Hechi Chemical Co., Ltd and changed its name to Guangxi Chisage Fine Chemical Technology Co., Ltd. in May 2026. Guangxi Chisage Fine Chemical Technology Co., Ltd. was founded in 1969 and is headquartered in Hechi, China.
Guangxi Hechi Chemical Co Ltd management
1- Ji LeiAccounting Supervisor